All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

PSA Testing Linked to Reduced Mortality

March 15th 2012

PSA testing was shown to significantly reduce mortality among men, but the test had no effect on all-cause mortality.

Zytiga Study Unblinded Following Positive Interim Analysis

March 9th 2012

A phase III study of abiraterone acetate in chemotherapy-naive patients with mCRPC has been unblinded following a positive interim analysis.

Top 5 Contagion® News Articles for the Week of August 27, 2017

March 6th 2012

Stay up-to-date on the latest infectious disease news by checking out this snapshot of our top 5 articles of the week.

Vemurafenib Doubles Median Survival in Metastatic Melanoma Patients

March 5th 2012

Vemurafenib nearly doubles the median OS in more than 50% of patients with BRAF V600-mutated metastatic melanoma.

Differentiating Age-Associated Memory Decline

March 5th 2012

Researchers propose a simple process to identify significant memory and cognition disorders.

Removal of Polyps Prevents Colorectal Cancer Deaths

February 27th 2012

Researchers confirm that polyp removal has long-term benefits.

FDA Takes Aggressive Steps to Reduce Drug Shortages

February 21st 2012

The FDA announced plans to strengthen the supply of 2 scarce cancer drugs: methotrexate and Doxil.

Electronic Health Records

February 20th 2012

Ten rights and responsibilities of users identified.

Radiation Therapy After Surgery Shows No Survival Benefit for Elderly Lung Cancer Patients

February 13th 2012

Many older patients with stage III lung cancer who received radiation therapy fared no better than those who did not receive radiation therapy.

Outpatient Electronic Prescriptions

February 13th 2012

Surprisingly, error rates are consistent with handwritten prescriptions.

FDA Updates: Pertuzumab Moves Forward, Denosumab Receives Setback

February 8th 2012

While pertuzumab is moving ahead in the FDA approval process, an additional indication for denosumab might be halted.

Expanded Use of Gleevec Approved in Patients With GIST

February 1st 2012

The FDA granted regular approval for imatinib for treating patients after the surgical removal of KIT-positive GISTs.

Vismodegib, First Hedgehog Inhibitor, Approved for BCC Patients

January 30th 2012

The FDA has approved vismodegib for the treatment of patients with basal cell carcinoma.

Cancer Screening

January 30th 2012

Utilization rates of cancer screening tests are lower than national target rates.

FDA Approves Axitinib for Advanced Kidney Cancer Patients

January 27th 2012

The FDA approved axitinib for the treatment of patients with advanced RCC who have failed to respond to another drug.

Oral HPV Infections More Prevalent in Men

January 26th 2012

Approximately 7% of Americans carry the human papillomavirus (HPV) in their oral cavities, and men are 3 times more likely to carry the virus than women.

BRCA1 and BRCA2 Mutations Yield Better Prognosis in Ovarian Cancer Patients

January 25th 2012

Patients with ovarian cancer who express BRCA1/2 mutations demonstrated a better overall survival after 5 years.

Electronic Cigarettes

January 25th 2012

Are electronic cigarettes "a miracle" as some users claim, or an unproven-and potentially harmful-smoking cessation aid?

FDA Approves Genzyme's Fabrazyme Plant

January 24th 2012

Genzyme Corporation announced that the FDA has approved its new manufacturing plant in Framingham, Massachusetts.

Bortezomib Approved for Subcutaneous Injection

January 24th 2012

The FDA has deemed subcutaneous injection as a safe and valid method of delivering the drug bortezomib in patients with multiple myeloma.